NCT01257594 2023-05-25EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant GliomasColumbia UniversityPhase 1 Completed22 enrolled
NCT02238496 2023-05-25Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasColumbia UniversityPhase 1 Completed10 enrolled